Click here to see a list of our past events.
Center for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours are open to all who wish to gain more information about the advancement of their patent filings and to discuss their technology venture project with a one-on-one meeting with a Weill Cornell business development and licensing professional.
This month's office hours will be hosted by Louise Sarup, Ph.D., associate director, business development and licensing. Louise manages a portfolio of medical technologies focusing on imaging, platform technologies and algorithms. She is a seasoned professional with years of experience in licensing and commercialization and is eager to answer your questions and provide valuable insights.
Prior to joining the Center for Technology Licensing, Louise was based in Singapore where she was head of business development and licensing for D3 (now EDDC), a drug discovery and development group based at A*STAR. Some of her previous roles include corporate development manager at S*BIO Pte Ltd. (Singapore), an oncology-focused biotech, vice president of business development at Paramount Biosciences (London), where she was responsible for in-licensing drug development assets and director (licensing) at Cytiva, a global life science company. Louise has also worked for leading life science and health care communication agencies and UCL Business, the commercialization company of University College London.
Register here for your 30-minute private session.
Join the leadership at Center for Technology Licensing (CTL) for the first in our Lab to Impact series, where we focus on intellectual property and guide you through the essential steps of the technology commercialization process. You will gain insights into the end-to-end process, from initial invention disclosure to IP protection, licensing and ultimately, commercialization. Learn how CTL’s support can help you maximize the impact of your research by successfully navigating the complexities of the commercialization journey.
Join us as we welcome Cornell University alumna Dr. Kate Rochlin, President & COO of IN8Bio, Inc., to share her career journey in a candid conversation with Loren Busby, Director of BioVenture eLab.
This event kicks off the Accelerating BioVenture Innovation (ABI) program, a 15-week course and training in biomedical entrepreneurship for students and postdoc trainees, designed to build interdisciplinary teams around patented, unlicensed technologies from Weill Cornell Medicine and neighboring institutions.
It is also a valuable opportunity to meet ABI program participants and network with peers from neighboring institutions as we begin forming project teams for the semester.
We look forward to seeing you there and launching a new season of innovation and entrepreneurship.
NSF I-Corps: Explore your innovation’s potential for societal & economic impact!
Virtual and conference-based courses led by the Interior Northeast I-Corps Hub.
Could your innovative research change the world?
Participate in a free, month-long I-Corps Regional Course to receive expert guidance as you evaluate the market potential of your deep technology innovation. You’ll gain a deeper understanding of your field and learn valuable professional skills in the process.
September 28 – October 28: For researchers developing medtech innovations. Includes travel to Boston, MA for The MedTech Conference.
Apply by September 2.
Are you a graduate student or postdoc interested in developing commercialization skills to work effectively in industry, broaden the scope of applications for your scientific knowledge, or launch your own startup? Would you value the opportunity to collaborate on a meaningful team project and strengthen your leadership skills?
If so, we invite you to participate in the Accelerating BioVenture Innovation (ABI) course this fall. ABI is a 15-week course that brings together interdisciplinary teams to develop commercialization plans around patented, unlicensed technologies from WCM and neighboring institutions. Teams are matched with industry mentors as well as MBA students and/or graduates. The commercialization plans take the form of investor pitches and are presented to a panel of venture capitalists and industry leaders in a final pitch contest at the end of the semester.
Whether you already have a product idea or are simply curious about innovation and entrepreneurship, now is the time to gain hands-on experience. Participants develop a practical understanding of the commercialization process for academic inventions and engage directly with real-world, patented life science inventions. The course attracts graduate students, postdocs, and other trainees from the Tri-I community, Cornell Tech, and Upper East Side hospitals. It is a great way to network with like-minded individuals across the ecosystem and be introduced to industry representatives that could be helpful as you advance in your career.
Do you have a late-stage discovery project in cancer and want to learn how the SBIR/STTR program can help advance your research toward commercialization?
Are you considering collaborating with industry or launching a startup to de-risk and commercialize your invention?
The day will begin with an overview of the NCI SBIR/STTR program at BioVenture eLab from 11:00am to 12:00pm. This session will also be broadcast via Zoom. During the presentation, Drs. Twomey and Li will explain how the SBIR/STTR program differs from traditional grant funding, discuss recent changes Congress made during the program’s reauthorization, and highlight what applicants need to know to prepare competitive proposals.
In the afternoon, Drs. Twomey and Li will hold 1:1 meetings with inventors from 12:30pm to 5:00pm. If you are looking to apply for an SBIR/STTR grant for the first time or have previously applied and plan to resubmit, please don’t miss this opportunity to receive guidance from these experienced NCI representatives. Meeting slots are limited and expected to fill quickly, so we encourage you to RSVP as soon as possible.
BioVenture eLab will host Dr. Sara Glickstein Bar-Zeev (Ph.D. '00), principal clinical scientist in Genentech's gRED OMNI Early Clinical Development group, for a discussion on drug development and clinical research.
Drawing on her experience leading first-in-human and proof-of-concept clinical trials, Dr. Glickstein Bar-Zeev will explore how translational science helps reduce uncertainty in early drug development, the evolving clinical research landscape, and the growing opportunities for collaboration between academia and industry.
A Weill Cornell Medicine alumna with a doctorate in neurobiology, Dr. Glickstein Bar-Zeev joined Genentech in 2017 after a decade in medical communications focused on publication strategy and medical writing. She previously held research faculty appointments at Weill Cornell Medicine and Columbia University, completed fellowships in ophthalmology and psychiatry, and has authored more than 30 peer-reviewed publications.
Whether you are a researcher, clinician, student, or industry executive, this conversation will offer valuable insights into key decisions to be made during each phase of clinical development.
Everything you need to know before applying for SBIR/STTR startup funding!
On Tuesday, August 4 at 11 a.m. ET, Kirk Macolini of InteliSpark will lead a free virtual workshop on the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) application process. Join us to learn how to secure non-dilutive funding for your startup.
You will learn:
- How to craft a successful SBIR/STTR application
- Strategies for developing a competitive proposal
- The latest news about the SBIR/STTR program
Do you have ideas for a new medical device to improve patient care or a tool to support your current medical training objectives? Do you need assistance translating these ideas into a graphic design and printing a 3D prototype?
BioVenture eLab is hosting an introductory 3D printing class on Thursday, July 23, 3-5pm in its MakerSpace (1157 York Ave). Learn 3D printing basics and how to workshop your medical device projects. In addition to learning how to use specialized software to create designs for 3D printing, topics covered in this seminar will include:
- biodesign concepts
- how to use design software to refine and augment your designs
- tips for using a 3D printer to generate an initial prototype
The seminar will feature Dylan Manuele, a Weill Cornell Medicine medical student who possesses a biomedical engineering degree from the University of Rochester.
Are you a STEM researcher interested in making an impact with your technology innovation? The National Science Foundation’s I-Corps program can provide you with professional training, mentoring, and up to $50,000 in funding for customer discovery.
Hosted by the Interior Northeast I-Corps Hub (IN I-Corps), the virtual NSF I-Corps Information Session on Wednesday, July 15 (12:00 – 12:45 p.m. ET) is designed for busy graduate students, postdocs, and faculty interested in learning more about I-Corps regional and national programming. NSF I-Corps instructor Caroline Cannon and program alum Hannah Stolrow will be in attendance to share their experience and answer questions.
The NSF created I-Corps (Innovation Corps) to bridge the gap between fundamental research discoveries in science and engineering and the commercialization of technologies, products, and processes with the potential to benefit society.
Register: https://www.eventbrite.com/e/1981025652053?aff=oddtdtcreator
